evaluate the pharmaceuticals company saxenda on glp-1 and insurance providers Perspectives from employers costs issues associated with covering agonists for weight loss How to Find a Health
Description
Your care should be, too
Bot Verification Verifying that you are not a robot...
Apparently, anybody
In a study published in JAMA Network Open in January 2025, which included more than 125,000 patients, nearly 65 percent of those taking GLP1s for reasons other than Type 2 diabetes discontinued them within one year
30 Bouchoucha, M., B
Isaacs says that while most people can safely take a GLP-1, you should avoid it if you have severe gastroparesis (stomach paralysis)
